We would love to hear your thoughts about our site and services, please take our survey here.
Tommy, you bought more shares at 24p, the price ended trading today at 12.9p.
This doesn’t annoy you that you are 45% down on your latest investment?
When there is zero news by end of March, what will you start to say? Will that be the time when you finally criticise Marsden?
Jonnyboy, the CEO Marsden did give an update.
He said he was working at haste to get the company’s only drug on to a free trial.
So far he hasn’t managed to get it on to a free trial hence no more to add in 11 months.
Other biotech companies have multiple drugs in their pipelines and all on different trials. Synairgen have one drug that they’ve been trying to get approved for 20 years, but now they want a free trial because they don’t have enough money to fund their own.
Tommy, what happened?
:-D
It always creases me up, I remember before the calamity happened you were one shouting ‘He wants to buy your cheap shares, he works for polygon’ :-D
This is a joy to behold, watching the calamity unravel even further and now seeing the likes of yourself and others desperately trying to ramp this rubbish dud.
You first touted the old Bill Gates line.
Then you touted STRIVE.
Then you had a secret profile touting a SPAC merger was due to happen.
Then you touted a JV.
It’s been a year of Marsden, the man you refuse to criticise ‘working at haste’, yet not a single update on what he’s working towards
:-D
This is joyful to see. The ramping still continues.
How is your return going on the shares you bought for 24p?
Polygon were trying to lower their average so that they can exit this dud as well.
Now your ramp has become ‘But polygon are invested’, hehe :-D
It’s beautiful, thank you :-D The share price is 12.9p
Early morning start for me n hubby in Scottsdale at the moment. Happy Valentines to y’all
Next week marks the anniversary of the sprinter calamity. It’s been a year with zero news of any progress but still certain members on here are booming with optimism (maybe they work for Synairgen and are told to post on this forum because there is nothing else to report?)
We know that Marsden is working at haste, but what do you think will happen to the share price with zero news in another few more months?
Drew x
We’ve been through this multiple times before over the last 2 solid years. The flurry happens on a Friday and if there is no RNS on the Monday they share price will tank 7-15% during the week. It will rise up again on the Friday again, people hedging their bets for a Monday morning RNS
I have no idea what RNS people are expecting seeing as the company’s single research drug is not on a trial and the company do not have enough money to fund their own trial, but that’s the stock market for you.
Currently the situation is that Synairgen are begging for handouts from governments or big pharma to fund a free trial on their single asset which already failed its own P3 trial.
You can read much of what the forum says with a pinch of salt, it’s all designed to try and make you believe that somehow Synairgen have this wonder drug that is desperately needed now more than ever. The truth is far far away from that.
They are a biotech (using that word very loosely) company that has not done any biotech in a whole year. They have a single failed drug in their pipeline and don’t have enough money to make a trial for that drug either. In other words, the company are in a misfortunate position of having to beg for handouts.
The CEO says nothing, no updates, no strategy planning updates, no directional thinking, so it is up to various individuals on this forum for whatever reason they have (either hired by Synairgen or by other parties, or just because they are a total fantastical zealot in the company as the Motley Fool once called them). They continue to post up little bits of information unrelated to Synairgen, but try to make out that somehow Synairgen ‘could’ be used for this, or Synairgen ‘might’ be in the running for that.
Any long term holder knows that it’s nonsense, the company failed and now is begging for money/trials.
Usually companies that have to beg for things don’t end up turning out very well.
What’s happened to the free trial that Marsden said he was working at haste to get Synairgen on?
A year without any biotech actually happening, that’s very strange for a ‘biotech company’.
:-/
STRIVE hasn’t happened for them, it now appears that the latest ramp is that a big pharma company will be joining with Synairgen and developing the drug. Although there has been absolutely no evidence of this at all, rampers simply plucking out of thin air.
As per usual, rampers pump out ‘what ifs’ and expect people to buy in to this dud.
As it stands, Synairgen is years away from getting their single drug approved. They aren’t even on a trial and it has already failed its P3 trial.
Maybe in another 20 years?
Good weekend. Drew :-D
A real shame that Synairgen’s only drug is so long away from any potential market breakthrough, if it ever gets approved. There’s absolutely no chance of SNG001 being sold in Japan to combat the deaths because it failed its P3 trial and isn’t on another trial either. It will take years to get approved and make any sales.
Could there Japanese government buy some Molnupiravir or Paxlovid to help the situation?
I find it amusing that absolutely nothing you ramped about in the last year has ever come true
You’ve lost money when you said it was a bargain at 24p and claimed you bought in.
You lied about STRIVE continuously
You lied about Pfizer
You keep lying.
Later in the week you’ll put up a post talking about how interferons could be the future according to a little obscure study that no one cares about
Dude, you’re 40% down on your new buy in price and still there is zero news from Synairgen in an entire year
What’s your game? You work for Synairgen right?
How are all the ramps coming along today?
Apparently Synairgen were supposed to be on STRIVE last May, then it was definitely by July, then definitely by September. Are they are on STRIVE yet?
Hows the SPAC coming along? Have they merged with a billion dollar SPAC yet?
How’s the joint venture going on? Have Pfizer chosen Synairgen as their joint venture? Hmm, slightly odd that they’d go from doing a JV with BioNTech, a hugely successful vaccine company in their own right with multiple vaccines in trials and a huge success rate, compared to a JV with Synairgen who have nothing in trials and only have a single research drug that failed it’s own P3 trial.
Keep up the ramps, imagine if you weren’t ramping, this company would go down to 3p
Daneeka shush! When did you finally wake up and realise the truth?
You’re not allowed to tell these people that the AGILE trial will have nothing to do with Synairgen because the intention of the post was to PRETEND that Synairgen have a chance of getting on a free trial.
It’s all just pretence, ramping, trying to keep that glimpse of hope alive.
There are no free trials for FAILED DRUGS now.
SNG001 failed. Synairgen, like any other biotech company need to raise their own money to perform their own trial. That’s how this works. They fluffed it.
Dudio, straightforward answer.
It’s because I enjoy telling people who are totally deluded and still somehow believe that Marsden (after 20 years of failure) will make a success.
The delusion is so great, so complete, they’ve been talking about STRIVE (back in May), didn’t happen. They’ve been talking about free trials, didn’t happen, yet now they’re talking about a SPAC. Next it’ll be Elon Musk is rumoured to be buying Synairgen. Then it’ll be Donald Trump rumoured to be buying them. It’s the same ramping garbage from these people over and over, yet every single time it never happens.
They know nothing about biotech companies, if they did then they would know that a company that has a single unapproved drug that hasn’t been on a trial for a year is a total pile. Why would a SPAC merge with a failed British biotech company that doesn’t even have a drug on a trial? There are hundreds of American biotech companies that already have multiple drugs on trials.
I enjoy looking at the ramping and pumping of this stock by people who clearly have some agenda to protect Marsden because he’s utterly hopeless.
See, straightforward answer.
You can see it now
6 months time, I come on here and ask what happened with the SPAC merger?
Share price is down at 8.5p and the same rampers start growling like attack dogs :-D
They keep on growling but refuse to go for Marsden hehe
We know why ;)
The fact that people on this forum are trying to rationalise and debate Synairgen merging with a SPAC is the equivalent of making up a story like Elon Musk plans to buy Synairgen.
Maybe that will be next weeks ramping story?
‘Musk plans to buy Synairgen’
Where did anyone even get the idea in their head that a total unknown nothing company like Synairgen would merge with a SPAC?
What if it was a SPAC for billionaires who want to lose all the money they’ve invested so that they can use it to offset their tax?
The next ramps will be that Donald Trump is thinking of buying Synairgen, setting up a SPAC to merge with a company that has a 20 year proven record of total failure so that he can use the losses to offset any tax
Doh, I’ve just given them their next ramping idea
:-D
SPAC and Bill Gates, pure comedy gold